Risks

Weak liquidity versus larger cannabis peers leaves IGC more exposed to working-capital shocks, while better-capitalized rivals can absorb inventory and receivable swings more easily.

Negative net debt is offset by a sub-0.4 current ratio, so near-term funding pressure could constrain growth execution more than for peers with stronger balance sheets.

Long inventory days versus faster-turning peers increase the risk of obsolescence and discounting, which can compress margins if demand remains uneven.

Extremely stretched payables indicate supplier dependence and potential settlement pressure, creating a higher disruption risk than peers with more balanced cash cycles.

Absent positive interest coverage and limited profitability visibility, IGC has less cushion than profitable peers if industry pricing weakens or capital access tightens.

Opportunities

If cannabis demand stabilizes, IGC’s low absolute leverage could support relative flexibility versus indebted peers, improving its ability to fund selective growth.

A negative cash conversion cycle can temporarily preserve liquidity, giving IGC more working-capital efficiency than peers that must finance inventory and receivables longer.

Should industry consolidation continue, smaller operators like IGC may benefit from niche positioning and lower fixed obligations versus larger, more complex peers.

Any easing in supplier terms or inventory normalization would improve cash generation faster than for peers already operating near efficient working-capital levels.

Overall Score

IGC’s low leverage and potential working-capital flexibility are offset by weak liquidity, slow inventory turnover, and limited earnings cushion versus better-capitalized peers.